2020-08-28
HOME
BROWSE
ARKIVOC
ABOUT
ARKIVOC
SEARCH
ARKIVOC
CONFERENCES
FLOHET/OTHERS
MONTHLY
NEWSLETTER
DONATE
Browse ARKIVOC
Submit Your Paper
Instructions:
Papers, Accounts, Reviews
Templates:
Papers
Accounts, Reviews
Commemorative Issues:
Aims and Procedures
Regional Issues:
Aims and Procedures
We thank OAKWOOD CHEMICAL for their generous support of Arkivoc and the FloHet Conferences

BROWSE ARKIVOC

3. Combined drug design of potential Mycobacterium tuberculosis and HIV-1 inhibitors: 3’,4’-di-substituted -4'H-spiro[isothiochromene-3,5'-isoxazol]-4(1H)-one (07-2701JP)
B. Bennani, A. Kerbal, M. Daoudi, B. Filali Baba, G. Al Houari, A. F. Jalbout, M. Mimouni, M. Benazza, G. Demailly, M. Akkurt, S. Öztürk Yıldırım and T. Ben Hadda
DOI: https://doi.org/10.3998/ark.5550190.0008.g03
Full Text: PDF (686K)
Export Citation: RIS
pp. 19 - 40


received Aug 10 2007; accepted Oct 30 2007; published Nov 5 2007;


CLOCKSS system has permission to ingest, preserve, and serve this Archival Unit

Let's Encrypt Trusted Site Seal